GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.

As one of Turkey’s fastest-growing pharmaceutical companies, since 1998 we have been delivering solutions worldwide for rare diseases and unmet medical needs. With a broad product portfolio, an innovation-led approach and specialist teams operating internationally, we work within ethical and scientific principles toward becoming a significant global healthcare brand. We are a 100% Turkish publicly listed company with 10 offices in 7 countries and 500+ employees. The GEN manufacturing plant is about 37 km from Ankara in ASO Organized Industrial Zones 2 and 3, on roughly 43,000 m² with 15,000 m² of covered area. Opened in 2017, the cGMP/GSP/GDP/GLP-compliant site has been inspected and GMP-certified by authorities including EMA, Turkey, Russia, Kazakhstan, the Philippines and Azerbaijan. The plant manufactures sterile liquid ampoules, liquid vials, lyophilized vials, prefilled syringes and cartridges as well as tablets, film-coated tablets, hard gelatin capsules and sachets, with stated capacities of 40 million packs/year (sterile) and 20 million packs/year (non-sterile). Products are supplied primarily to Turkey and also to Russia, Georgia, Uzbekistan, Kazakhstan, Azerbaijan, the Philippines and Albania. The GEN R&D Center inside the plant (ASO OIZ 2) has 1,200 m² of laboratories and was approved as an R&D center by Turkey’s Ministry of Industry and Technology in 2019, developing pharmaceutical dosage forms in formulation and analytical development labs.